Evaluation of genotoxicity testing of FDA approved large molecule therapeutics-Reference-Cited by-同舟云学术

Evaluation of genotoxicity testing of FDA approved large molecule therapeutics

Published:2014-10 Issue:1 Volume:70 Page:87-97
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Sawant Satin G.,Fielden Mark R.,Black Kurt A.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference42 articles.

1. Abatacept, 2005. FDA pharmacology review. (Weblink last assessed on May 23, 2014).

2. On the possible origins of DNA damage in human spermatozoa;Aitken;Mol. Hum. Reprod.,2010

3. DNA damage and repair: from molecular mechanisms to health implications;Altieri;Antioxid. Redox Signal.,2008

4. Efficient method for production of high yields of Fab fragments in Drosophila S2 cells;Backovic;Protein Eng. Des. Sel.,2010

5. Introduction to current and future protein therapeutics: a protein engineering perspective;Carter;Exp. Cell Res.,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspects of complexity in quality and safety assessment of peptide therapeutics and peptide-related impurities. A regulatory perspective;Regulatory Toxicology and Pharmacology;2024-11

2. Multiparametric in vitro and in vivo analysis of the safety profile of self-assembling peptides;Scientific Reports;2024-02-22

3. Preclinical Development of Antibody–Drug Conjugates;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

4. Protein Therapeutics;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023

5. Romiplostim use in pregnant women with immune thrombocytopenia;American Journal of Hematology;2022-10-10